FDA flags safety risk with Boston Scientific stents after reports of deployment issues causing deaths and injuries, prompting a Class I recall.

Boston Scientific has issued an FDA warning letter recommending removal of 1,660 lots of AXIOS Stent and Electrocautery Enhanced Delivery Systems due to increased reports of stent deployment and ...

Add Yahoo as a preferred source to see more of our stories on Google. Boston Scientific's headquarters is in Marlborough, Massachusetts. (Courtesy of Boston Scientific) This story was originally ...

MOUNTAIN VIEW, Calif., July 17, 2012 /PRNewswire/ -- Xlumena, Inc. announces that it has received CE Mark approval to market its AXIOS Stent and Delivery System for biliary tract drainage. The device ...

The RAINBOW study, officially titled “French Prospective Study on Biliary Tract Drainage Guided by Endoscopic Ultrasound in Patients With Malignant Biliary Stenosis (RAINBOW),” evaluates Boston ...

In a bid to extend its footprint in the multibillion-dollar endoscopy equipment market, Boston Scientific Corporation BSX has commercially launched its FDA-cleared Axios stent and electrocautery ...